Tuesday 23 Apr 2024
By
main news image

KUALA LUMPUR (Aug 17): TPG Capital Asia, the Asian investment platform of global alternative asset firm TPG, has completed the acquisition of Gribbles Pathology (M) Sdn Bhd, which operates 37 pathology facilities in Malaysia.

TPG said the acquisition forms part of its A$279 million (RM831.9 million) purchase of Healthscope Ltd's Asian pathology laboratories in Malaysia, Singapore, and Vietnam.

In Malaysia, these laboratories operate under the brand "Gribbles Pathology", while in Singapore and Vietnam, they are known as "Quest Laboratories".

"We hope to be able to continue to grow our presence in Malaysia and at the same time be a leader in the application of new technology and quality of service to the doctors and healthcare professionals that depend on us," said Gribbles' incoming chairman Tan Sri Dr Yahya Awang said in a statement today.

TPG's investments in Asia include Manipal Hospitals in India, United Family Healthcare in China, Novotech and Healthscope in Australia, and the Jetanin Institute for Assisted Reproduction in Thailand.

TPG's latest venture also comes alongside its investments that have a strong presence in Malaysia, including PropertyGuru and TE Asia Healthcare with Cardiac Vascular Sentral Kuala Lumpur.

      Print
      Text Size
      Share